These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 7032959

  • 1. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP, Meredith RF, Raikow RB, Brozovich BJ, Magliere K.
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [Abstract] [Full Text] [Related]

  • 2. Histocompatibility influence in allogeneic marrow transplantation therapy of murine viral leukemia. I.--Studies of the relative influence of major versus minor histocompatibility determinants.
    Meredith RF, Okunewick JP, Raikow RB, Brozovich BJ, Seeman PR, Magliere KC.
    Biomedicine; 1981 Feb; 34(1):11-7. PubMed ID: 7013840
    [Abstract] [Full Text] [Related]

  • 3. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
    Palathumpat V, Holm B, Dejbakhsh-Jones S, Strober S.
    J Immunol; 1992 May 15; 148(10):3319-26. PubMed ID: 1578152
    [Abstract] [Full Text] [Related]

  • 4. The role of CD4 and CD8 T cells in the graft-versus-leukemia response in Rauscher murine leukemia.
    OKunewick JP, Kociban DL, Machen LL, Buffo MJ.
    Bone Marrow Transplant; 1991 Dec 15; 8(6):445-52. PubMed ID: 1686416
    [Abstract] [Full Text] [Related]

  • 5. Evidence for a possible role of Asialo-GM1-positive cells in the graft-versus-leukemia repression of a murine type-C retroviral leukemia.
    OKunewick JP, Kociban DL, Machen LL, Buffo MJ.
    Bone Marrow Transplant; 1995 Sep 15; 16(3):451-6. PubMed ID: 8535319
    [Abstract] [Full Text] [Related]

  • 6. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M, Uharek L, Glass B, Gaska T, Gassmann W, Mueller-Ruchholtz W.
    Bone Marrow Transplant; 1994 Nov 15; 14(5):711-5. PubMed ID: 7889004
    [Abstract] [Full Text] [Related]

  • 7. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
    Zeis M, Uharek L, Glass B, Vosskötter W, Dreger P, Schmitz N, Steinmann J.
    Exp Hematol; 1998 Oct 15; 26(11):1068-73. PubMed ID: 9766447
    [Abstract] [Full Text] [Related]

  • 8. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD, Drobyski WR, Truitt RL.
    Bone Marrow Transplant; 1993 Apr 15; 11(4):329-36. PubMed ID: 8485480
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of CD3 and CD5 donor T cell depletion on graft-versus-leukemia in a murine model for MHC-matched unrelated-donor transplantation.
    Okunewick JP, Kociban DL, Machen LL, Buffo MJ.
    Bone Marrow Transplant; 1994 Jan 15; 13(1):11-7. PubMed ID: 7517254
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukemia in SJL/J mice.
    Vourka-Karussis U, Karussis D, Ackerstein A, Slavin S.
    Exp Hematol; 1995 Mar 15; 23(3):196-201. PubMed ID: 7875238
    [Abstract] [Full Text] [Related]

  • 11. Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ, Esparza AR, Flinton LJ, Simon JD, Kelley RJ, Albala MM.
    Cancer Res; 1977 Oct 15; 37(10):3494-6. PubMed ID: 20223
    [Abstract] [Full Text] [Related]

  • 12. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L, Reich S, Slavin S.
    Cytokines Cell Mol Ther; 1999 Sep 15; 5(3):145-52. PubMed ID: 10641572
    [Abstract] [Full Text] [Related]

  • 13. [Experimental study on immunotherapy with dendritic cell in leukemic mice model].
    Li XX, Chen XL, Ma DX, Liu CS, He XP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb 15; 27(2):73-7. PubMed ID: 16732955
    [Abstract] [Full Text] [Related]

  • 14. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC, Tielemans MJ, Martens AC, van Bekkum DW, Hagenbeek A.
    Bone Marrow Transplant; 1994 Jul 15; 14(1):15-22. PubMed ID: 7951103
    [Abstract] [Full Text] [Related]

  • 15. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH, Breglio J, Nagel G, Eckhaus MA, Gress RE.
    J Immunol; 1996 Dec 01; 157(11):4811-21. PubMed ID: 8943383
    [Abstract] [Full Text] [Related]

  • 16. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P, Vourka-Karussis U, Weiss L, Slavin S.
    J Immunol; 1993 Nov 01; 151(9):4803-10. PubMed ID: 8409438
    [Abstract] [Full Text] [Related]

  • 17. Graft-versus-leukemia effect in allogeneic bone marrow transplantation in mice against several radiation-induced leukemias.
    Aizawa S, Sado T, Kamisaku H, Nemoto K, Yoshida K.
    Bone Marrow Transplant; 1994 Feb 01; 13(2):109-14. PubMed ID: 8205078
    [Abstract] [Full Text] [Related]

  • 18. [Study of experimental mixed bone marrow transplantation].
    Luo H, Yang P, He F.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Aug 01; 19(8):418-21. PubMed ID: 11189509
    [Abstract] [Full Text] [Related]

  • 19. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD, Becker EE, Truitt RL.
    Biol Blood Marrow Transplant; 1999 Aug 01; 5(3):123-32. PubMed ID: 10392958
    [Abstract] [Full Text] [Related]

  • 20. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ, Esparza AR, Albala MM.
    Cancer Res; 1975 Mar 01; 35(3):637-9. PubMed ID: 234789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.